Maryll W. Toufanian
Corporate Officer/Principal at AMNEAL PHARMACEUTICALS, INC.
Profile
Maryll W.
Toufanian is currently the Senior Vice President-Regulatory Strategy & Policy at Amneal Intermediate, Inc. and also holds the position of Senior VP-Regulatory Strategy & Policy at Amneal Pharmaceuticals, Inc. She has an undergraduate degree from the University of Maine and graduate degrees from New York University School of Law and the University of Texas at Austin.
Maryll W. Toufanian active positions
| Companies | Position | Start |
|---|---|---|
| AMNEAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 2022-10-30 |
Training of Maryll W. Toufanian
| New York University School of Law | Graduate Degree |
| University of Texas at Austin | Graduate Degree |
| University of Maine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMNEAL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Maryll W. Toufanian
